INSIGHTS

NMPA

Regulatory Text

NMPA Introduces New Measures to Support Innovation of Cosmetic Raw Materials

Regulatory Analysis

China’s Cosmetics Industry Enters New Era

National Medical Products Administration unveils groundbreaking policy to drive raw material innovation, offering new opportunities for brands, researchers, and investors

Regulatory Update

Potential Relief for Cruelty-Free Cosmetics in China’s Future Regulatory Landscape

Explore how the NMPA's latest draft opinion could open doors for cruelty-free cosmetic brands in China, potentially transforming market access strategies.

Regulatory Update, Industry Insight

Chinese Regulations on Nanomaterials in Cosmetics: The Case of Exosomes

Regulatory Analysis, Industry Insight

Streamlining Global Cosmetic Testing: Bridging EU/UK and Chinese Regulatory Requirements

Discover how aligning cosmetic testing protocols between China and the EU/UK can significantly reduce time and costs for market entry, optimizing your global expansion strategy.

Series, Regulatory Text

NMPA Guidelines for Submission of Cosmetics Safety Assessment, China Part III.6

Series, Regulatory Text

NMPA Guidelines for Submission of Cosmetics Safety Assessment, China, Part III.5

Outline the specific procedures and requirements for safety assessments of cosmetic products under special circumstances.

Series, Regulatory Text

NMPA Guidelines for Submission of Cosmetics Safety Assessment, China, Part III.4

Outline the procedures for safety testing when ingredient-level assessments are not feasible or complete.

Series, Regulatory Text

NMPA Guidelines for Submission of Cosmetics Safety Assessment, China, Part III.3

Outline safety assessment guidelines for specific cosmetic ingredients in China, focusing on special consideration due to unique properties or potential risks.

Series, Regulatory Text

NMPA Guidelines for Submission of Cosmetics Safety Assessment, China, Part III.1

Outline the general principles and self-inspection points for safety assessment reports.

Series, Regulatory Text

NMPA Guidelines for Submission of Cosmetics Safety Assessment China, Part I

Introduction of a comprehensive framework for evaluating and documenting the safety of cosmetic products in China.

Regulatory Analysis

Navigating China’s Drug Instruction and Labelling Regulations

Explore the details of China's drug instruction and labeling requirements to ensure regulatory compliance and optimize patient safety in the world's second-largest pharmaceutical market.

Regulatory Analysis

Guidelines for Cosmetic Efficacy Claims and Evaluation Requirements

Regulatory Analysis, Industry Insight

Navigating the Maze

Dive deep into China's OTC drug registration process, exploring overseas clinical trial acceptance, first-in-market opportunities, and local testing requirements. Gain crucial insights for successful market entry and regulatory compliance in this comprehensive guide.

Regulatory Analysis, Industry Insight

Navigating China’s Evolving Drug Registration Landscape: A Comprehensive Guide for Regulatory Professionals

Regulatory Text

Administrative Measures for Drug Registration

Outline comprehensive regulations for drug research, registration, and market authorization, ensuring safety, efficacy, and quality control across TCM, chemical drugs, and biological products.

add_filter( 'wp_get_attachment_image_attributes', 'remove_lazy_load_attribute', 10, 3 ); function remove_lazy_load_attribute( $attributes, $attachment, $size ) { if ( isset( $attributes['class'] ) && strpos( $attributes['class'], 'lazy-free' ) !== false ) { unset( $attributes['loading'] ); } return $attributes; }